HEADER TRANSFERASE 27-FEB-17 5NA0 TITLE TTK KINASE DOMAIN IN COMPLEX WITH A PEG-LINKED PYRIMIDO-INDOLIZINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE,PYT; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, MITOSIS, MPS1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.UITDEHAAG,N.WILLEMSEN-SEEGERS,J.DE MAN,R.C.BUIJSMAN,G.J.R.ZAMAN REVDAT 5 17-JAN-24 5NA0 1 REMARK REVDAT 4 23-AUG-17 5NA0 1 REMARK REVDAT 3 05-JUL-17 5NA0 1 JRNL REVDAT 2 07-JUN-17 5NA0 1 JRNL REMARK REVDAT 1 31-MAY-17 5NA0 0 JRNL AUTH J.C.M.UITDEHAAG,J.DE MAN,N.WILLEMSEN-SEEGERS,M.B.W.PRINSEN, JRNL AUTH 2 M.A.A.LIBOUBAN,J.G.STERRENBURG,J.J.P.DE WIT,J.R.F.DE VETTER, JRNL AUTH 3 J.A.D.M.DE ROOS,R.C.BUIJSMAN,G.J.R.ZAMAN JRNL TITL TARGET RESIDENCE TIME-GUIDED OPTIMIZATION ON TTK KINASE JRNL TITL 2 RESULTS IN INHIBITORS WITH POTENT ANTI-PROLIFERATIVE JRNL TITL 3 ACTIVITY. JRNL REF J. MOL. BIOL. V. 429 2211 2017 JRNL REFN ESSN 1089-8638 JRNL PMID 28539250 JRNL DOI 10.1016/J.JMB.2017.05.014 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 9576 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1049 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 687 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.3900 REMARK 3 BIN FREE R VALUE SET COUNT : 62 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2079 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 83.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.907 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.386 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.292 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.223 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.894 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2184 ; 0.013 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2118 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2952 ; 1.861 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4894 ; 0.970 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 251 ; 7.020 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;45.722 ;25.510 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 403 ;20.329 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;18.389 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 316 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2391 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 476 ; 0.008 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5NA0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003757. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10632 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 80.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 1.08500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 5N7V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 32 - 37% PEG400 (ACROS, GEEL, REMARK 280 BELGIUM), 0.1 M NA/K PHOSPHATE PH 6.3 AND 250 MM NACL.PH 6.3, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.64000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.90500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 56.64000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.90500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 56.64000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.90500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 56.64000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.90500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 PHE A 515 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 MET A 698 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 THR A 795 REMARK 465 HIS A 796 REMARK 465 LEU A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 561 OG1 THR A 564 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 517 132.18 -175.98 REMARK 500 SER A 536 57.85 -104.54 REMARK 500 LYS A 546 22.38 -74.30 REMARK 500 SER A 582 145.14 176.03 REMARK 500 LYS A 584 31.53 -93.75 REMARK 500 LYS A 617 -79.02 -64.82 REMARK 500 ASP A 647 41.18 -173.05 REMARK 500 ASP A 657 55.41 35.11 REMARK 500 TPO A 686 101.79 17.03 REMARK 500 LYS A 696 81.38 -156.41 REMARK 500 ASN A 739 105.84 -56.22 REMARK 500 PRO A 757 133.50 -26.02 REMARK 500 LEU A 772 52.30 -96.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8QZ A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5N87 RELATED DB: PDB REMARK 900 STRUCTURE DETERMINED UNDER SIMILAR EXPERIMENTAL CONDITIONS DBREF 5NA0 A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 5NA0 MET A 496 UNP P33981 INITIATING METHIONINE SEQADV 5NA0 HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 5NA0 HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 5NA0 HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 5NA0 HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 5NA0 HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 5NA0 HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 5NA0 SER A 503 UNP P33981 EXPRESSION TAG SEQADV 5NA0 SER A 504 UNP P33981 EXPRESSION TAG SEQADV 5NA0 GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 5NA0 VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 5NA0 ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 5NA0 LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 5NA0 GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 5NA0 THR A 510 UNP P33981 EXPRESSION TAG SEQADV 5NA0 GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 5NA0 ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 5NA0 LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 5NA0 TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 5NA0 PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 5NA0 GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 5NA0 SER A 517 UNP P33981 EXPRESSION TAG SEQADV 5NA0 MET A 518 UNP P33981 EXPRESSION TAG SEQADV 5NA0 LEU A 797 UNP P33981 PRO 797 CONFLICT SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS LEU VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU MODRES 5NA0 TPO A 686 THR MODIFIED RESIDUE HET TPO A 686 11 HET 8QZ A 901 55 HETNAM TPO PHOSPHOTHREONINE HETNAM 8QZ ~{N}-[3,5-DIETHYL-1-[2-[2-(2-METHOXYETHOXY) HETNAM 2 8QZ ETHOXY]ETHYL]PYRAZOL-4-YL]-2-[[2-METHOXY-4-[4-(2- HETNAM 3 8QZ METHOXYETHANOYL)PIPERAZIN-1-YL]PHENYL]AMINO]-5,6- HETNAM 4 8QZ DIHYDROPYRIMIDO[4,5-E]INDOLIZINE-7-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 8QZ C39 H53 N9 O7 FORMUL 3 HOH *8(H2 O) HELIX 1 AA1 ASP A 561 LEU A 578 1 18 HELIX 2 AA2 LEU A 609 LYS A 616 1 8 HELIX 3 AA3 ASP A 620 HIS A 641 1 22 HELIX 4 AA4 LYS A 649 ALA A 651 5 3 HELIX 5 AA5 PRO A 691 ILE A 695 5 5 HELIX 6 AA6 PRO A 713 GLY A 730 1 18 HELIX 7 AA7 ASN A 739 ASP A 749 1 11 HELIX 8 AA8 GLU A 761 LEU A 772 1 12 HELIX 9 AA9 SER A 781 HIS A 788 1 8 HELIX 10 AB1 HIS A 788 ILE A 793 1 6 SHEET 1 AA1 6 MET A 518 VAL A 520 0 SHEET 2 AA1 6 ARG A 523 GLY A 534 -1 O TYR A 525 N MET A 518 SHEET 3 AA1 6 SER A 537 LEU A 543 -1 O VAL A 539 N GLY A 532 SHEET 4 AA1 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA1 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA1 6 LEU A 588 ILE A 593 -1 N ASP A 590 O VAL A 601 SHEET 1 AA2 3 ILE A 607 ASP A 608 0 SHEET 2 AA2 3 PHE A 653 VAL A 656 -1 O ILE A 655 N ILE A 607 SHEET 3 AA2 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 LINK C GLY A 685 N TPO A 686 1555 1555 1.33 LINK C TPO A 686 N VAL A 687 1555 1555 1.32 SITE 1 AC1 20 ILE A 531 GLY A 534 SER A 537 VAL A 539 SITE 2 AC1 20 GLN A 541 ALA A 551 LYS A 553 VAL A 555 SITE 3 AC1 20 TYR A 568 ILE A 586 MET A 600 MET A 602 SITE 4 AC1 20 GLU A 603 CYS A 604 GLY A 605 ASN A 606 SITE 5 AC1 20 SER A 611 LYS A 615 LEU A 654 ASP A 664 CRYST1 71.100 113.280 115.810 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014065 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008828 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008635 0.00000